Role of murine NK cells and their receptors in hybrid resistance

Current Opinion in Immunology

Volumn 9, Issue 1, 1997, Pages 52-56

  Kumar, Vinay ^a   George, Thaddeus ^a   Yu, Yik Yeung Lawrence ^a   Liu, Jingxuan ^a   Bennett, Michael ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

BONE MARROW CELL; GRAFT REJECTION; HYBRID; IMMUNITY; KILLER CELL; LYMPHOMA CELL; NATURAL KILLER CELL; NEGATIVE FEEDBACK; REVIEW; T LYMPHOBLAST; TARGET CELL;

EID: 0031050717     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(97)80158-6     Document Type: Article

References (39)

1. Murphy WJ, Kumar V, Bennett M. Rejection of bone marrow allografts mice with severe combined immune deficiency (SCID). Evidence that natural killer cells can mediate the specificity of marrow graft rejection. J Exp Med. 165:1987;1212-1217.
2. Bennett M. Biology and genetics of hybrid resistance. Adv Immunol. 41:1987;333-445.
3. Yokoyama WM. Natural killer cell receptor. Curr Opin Immunol. 7:1995;110-120.
4. Yu YYL, Kumar V, Bennett M. Murine natural killer cells and marrow graft rejection. Ann Rev Immunol. 10:1992;189-213.
5. Rembecki RM, Kumar V, David CS, Bennett M. Bone marrow cell transplants involving intra-H2 recombinant inbred mouse strains. J Immunol. 141:1988;2253-2260.
6. Ljunggren HG, Kärre K. In search of the 'missing self': MHC molecules and NK cell recognition. Immunol. Today. 11:1990;237-244.
7. Öhlen C, Kling G, Höglund P, Hansson M, Scangos G, Bieberich C, Jay G, Kärre K. Prevention of allogeneic bone marrow graft rejection by H2 transgene in donor mice. Science. 246:1989;666-668.
8. Chadwick BS, Miller RG. Hybrid resistance in vitro: possible role of both class I MHC and self peptides in determining the level of target cell sensitivity. J Immunol. 148:1992;2307-2313.
9. Basiri H, Kiura K, DeNardin EG, Nakamura I. Allospecificities of B6D2F1 hybrid NK cell subsets defined by Ly49A expression. J Immunol. 155:1995;2822-2832.
10. Liu J, Yu YYL, Fischer-Lindahl K, Kumar V, Bennett M. Allorecognition by murine natural killer cells: studies with bone marrow transplants and lysis of T lymphoblasts. Chem Immunol. 1996;. in press.
11. Colonna M. Natural killer cell receptors for MHC class I molecules. Curr Opin Immunol. 8:1996;101-107.
12. P Transgene alters natural killer cell specificity at the target and effector cell levels. J Immunol. 156:1996;2329-2423.
13. d.
14. Brennan J, Mager D, Jeffries W, Takei F. Expression of different members of the Ly-49 gene family defines distinct natural killer cell subsets, cell adhesion properties. J Exp Med. 180:1994;2287-2295.
15. Stoneman E, Bennett M, An J, Chestnut KA, Wakeland EK, Scheerer J, Siciliano MJ, Kumar V, Mathew PA. Cloning and characterization of 5E6(Ly-49C), a receptor molecule expressed on a subset of murine natural killer cells. of special interest J Exp Med. 182:1995;305-313 This paper describes the cloning of Ly49C and its reactivity with mAb 5E6. A correction appears in J Exp Med 1996, 183:2705.
16. Brennan J, Lemieux S, Douglas Freeman J, Mager DL, Takei F. Heterogeneity among Ly-49C NK cells: characterization of highly related receptors with differing functions and expression patterns. of outstanding interest J Exp Med. 184:1996;2085-2090 Studies demonstrating that 5E6 mAb binds to two related genes Ly49C and Ly49I.
17. b bone marrow grafts. J Exp Med. 170:1989;191-202.
18. f. Eur J Immunol. 21:1991;2821-2828.
19. Yu YYL, George T, Dorfman JR, Roland J, Kumar V, Bennett M. The role of Ly49A and 5E6(Ly49C) molecules in hybrid resistance mediated by murine natural killer cells against normal T cell blasts. of outstanding interest Immunity. 4:1996;67-76 Studies described in this paper provide evidence that of missing-self hypothesis can explain hybrid resistance.
20. Zheng W-P, Kiura K, Milisauskas VK, DeNardin E, Nakamura I. Murine NK cell allospecificity-1 defined by inhibitory ligands. J Immunol. 156:1996;4651-4655.
21. b marrow cells in vivo.
22. d. Eur J Immunol. 24:1994;336-342.
23. Wong S, Freeman JD, Kelleher C, Mager D, Takei F. Ly49 multigene family. New members of a superfamily of type II membrane proteins with lectin-like domains. J Immunol. 147:1991;1417-1423.
24. Held W, Roland J, Raulet DH. Allelic exclusion of Ly49-family genes encoding class I MHC-specific receptors on NK cells. of outstanding interest Nature. 376:1995;355-358 Evidence for allelic exclusion of Ly49 family of genes.
25. Sundback J, Kärre K, Sentman CL. Cloning of minimally divergent allelic forms of the natural killer (NK) receptor Ly49C, differentially controlled by host genes in the MHC and NK gene complexes. of special interest J Immunol. 157:1996;3936-3942 This paper describes the influence of MHC genes and Ly49C alleles on expression of Ly49C. It also reports cloning of the B6 allele of Ly49C.
26. Lernieux S, Ouellet-Talbot F, Lusignan Y, Morelli L, Labreche N, Gosselin P, Lecomte J. Identification of murine natural killer cell subsets with monoclonal antibodies from 129 anti-C57BL/6 immune spleen cells. Cell Immunol. 134:1991;191-204.
27. - inbred mouse strains and their progeny. Cell Immunol. 141:1992;148-160.
28. Brennan J, Mahon G, Mager DL, Jeffries WA, Takei F. Recognition of class I major histocompatibility complex molecules by Ly49: specificities and domain interactions. J Exp Med. 183:1996;1553-1559.
29. George T, Yu YYL, Liu J, Davenport C, Lemieux S, Stoneman E, Mathew PA, Kumar V, Bennett M. Allorecognition by murine natural killer cells: lysis of T lymphoblasts and rejection of bone marrow grafts. Immunol Rev. 1997;. in press.
30. Sentman CL, Kumar V, Koo G, Bennett M. Effector cell expression of NK1.1, a murine natural killer cell specific molecule, ability of mice to reject bone marrow allografts. J Immunol. 142:1989;1847-1853.
31. Salcedo M, Höglund P, Achour A, Thorpe C, Ljunggren H-G. Altered MHC class I presented peptide repertoire is not sufficient to induce NK cell mediated F1-hybrid resistance. Mol Immunol. 32:1995;789-794.
32. Malnati MS, Peruzzi M, Parker KC, Biddison WE, Ciccone E, Moretta A, Long EO. Peptide specificity in the recognition of MHC class I by natural killer cell clones. of special interest Science. 267:1995;1016-1018 See annotation [33].
33. Correa I, Raulet DH. Binding of diverse peptides to MHC class I molecules inhibits target cell lysis by activated natural killer cells. of special interest Immunity. 2:1995;61-71 This paper, along with [32], reports on the effect of self/non-self peptides on recognition of class I molecules by NK cells.
34. Chadwick BS, Sambhara SR, Sasakura Y, Miller RG. Effect of class I MHC binding peptides on recognition by natural killer cells. J Immunol. 149:1992;3150-3156.
35. r molecules expressed on bone marrow cells. Intl Immunol. 6:1994;1297-1306.
36. Bennett M, D'Orazio T, Kumar V, Stenoien D, Blömer KC, Fischer Lindahl K. Bone marrow cell transplants involving donors and hosts with haplotypes derived from spretus mice. Transplantation. 59:1995;1452-1459.
37. Naper C, Rolstad B, Wonigeit K, Butcher G, Vaage JT. Genes in two MHC class I regions control recognition of a single rat natural killer cell allodeterminant. Int Immunol. 8:1996;. in press.
38. Mason LH, Anderson SK, Yokoyama WM, Smith HRC, Winkler-Pickett R, Ortaldo JR. The Ly-49D receptor activates murine NK cells. of outstanding interest J Exp Med. 184:1996;2119-2128 This is the first report of an Ly49 molecule that activates murine NK cells.
39. Smith HRC, Karlhofer FM, Yokoyama WM. The Ly49 multigene family expressed by IL-2-activated natural killer cells. J Immunol. 153:1994;1068-1079.